Peripheral vascular structure and function in hypertrophic cardiomyopathy

Nicola Jayne Rowley1, Daniel J Green, Keith George

  • 1Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK.

Insights

Hypertrophic cardiomyopathy (HCM) patients and athletes show distinct peripheral arterial differences, aiding in distinguishing pathological cardiac enlargement from exercise adaptations. These vascular changes highlight potential diagnostic markers beyond cardiac imaging.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Sports Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young athletes.
  • Differentiating physiological (athlete's heart) from pathological (HCM) cardiac remodeling is clinically challenging.
  • Peripheral vascular adaptations in HCM are poorly understood, despite known effects of training on vasculature.

Purpose of the Study:

  • To investigate peripheral vascular differences between HCM patients and athletes.
  • To determine if arterial structure and function vary between HCM, athletes, and controls.
  • To identify potential non-cardiac markers for differentiating HCM from exercise-induced cardiac changes.

Main Methods:

  • High-resolution ultrasound was used to measure carotid and brachial artery diameter and wall thickness.
  • Flow-mediated dilation (FMD) of brachial arteries was assessed.
  • Age-matched groups of HCM patients (n=18), competitive athletes (n=18), and controls (n=10) were studied.

Main Results:

  • Significant differences in carotid and brachial artery wall thickness were observed between athletes and HCM patients.
  • Athletes exhibited greater brachial artery peak blood flow response, indicating altered resistance artery remodeling compared to HCM patients.
  • No significant differences were found in brachial artery FMD% between the groups.

Conclusions:

  • Peripheral arterial structure differs between HCM patients and athletes, despite similar cardiac characteristics.
  • These vascular differences may stem from HCM pathology or a general effect of physical activity on arteries.
  • Further research is needed to explore artery function and structure in athletic individuals with HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...